Special Consideration

  1. All students entering the MD/PhD program will have either completed, or be in the final year of, a program leading to a four-year undergraduate degree at a recognized university, and expect to have obtained your degree by June 30th of the academic year in which application is being made.

    If currently enrolled in a graduate degree program, you must be in the final year of the program to be eligible to apply (for additional requirements and deadlines, please visit the MD Program Admission Requirements webpage).

    For students from areas of science, it will also provide the opportunity to evaluate research skills through the normal fourth year research project, and important component for assessing any candidate for most graduate programs. Applicants who have completed a masters’ thesis will have had substantially more research training as part of their program. This will ensure that the student has had sufficient intensity of study, academic training and some research training.

  2. Only Canadian Citizens or those holding Canadian Permanent Resident status will be considered for admission.
  3. Once applicants have submitted their application to OMSAS, there is a separate application for the combined MD/PhD program (see above) that must be submitted by December 1 of the year.
  4. If the application is considered to be sufficiently strong by the MD/PhD Committee, the applicant will be interviewed late winter. Final acceptance into this program will not be granted until a research supervisor and a mentorship committee has been determined, and is conditional on acceptance from the School of Graduate and Postdoctoral Studies.
  5. Once a suitable supervisor has been selected, students will apply to the appropriate graduate program through the regular process. For more information, on applying to grad studies, please visit the Graduate Studies and Postdoctoral Affairs at Schulich Medicine & Dentistry webpage.
  6. The student will be conditionally accepted into the MD/PhD program by April 15th.